Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells
Plunkett, W.; Chubb, S.; Alexander, L.; Montgomery, J.A.
Cancer Research 40(7): 2349-2355
1980
ISSN/ISBN: 0008-5472 PMID: 6966966 Document Number: 166666
Document emailed within 1 workday
Related Documents
Xie, C.; Plunkett, W. 1995: Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells Cancer Research 55(13): 2847-2852Klecker, R.W.; Katki, A.G.; Collins, J.M. 1994: Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells Molecular Pharmacology 46(6): 1204-1209
Townsend, A.; Leclerc, J.M.; Dutschman, G.; Cooney, D.; Cheng, Y.C. 1985: Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4) Cancer Research 45(8): 3522-3528
Helland, S.; Ueland, P.M. 1981: Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase Cancer Research 41(2): 673-678
Juranka, P.; Chan, V.L. 1980: Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate Cancer Research 40(11): 4123-4126
Espevik, T.; Figari, I.S.; Ranges, G.E.; Palladino, M.A. 1988: Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1 Journal of Immunology 140(7): 2312-2316
Parker, W.B.; Shaddix, S.C.; Rose, L.M.; Shewach, D.S.; Hertel, L.W.; Secrist, J.A.; Montgomery, J.A.; Bennett, L.L. 1999: Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells Molecular Pharmacology 55(3): 515-520
Caron, N.; Lee, S.H.; Kimball, A.P. 1977: Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210 Cancer Research 37(9): 3274-3279
Kim, I.Y.; Ahn, H.J.; Zelner, D.J.; Shaw, J.W.; Sensibar, J.A.; Kim, J.H.; Kato, M.; Lee, C. 1996: Genetic change in transforming growth factor beta (TGF-beta) receptor type i gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells Cancer Research 56(1): 44-48
Chan, V.L.; Guttman, S. 1985: Codominant and recessive 9-beta-D-arabinofuranosyladenine-resistant mutations of baby hamster cells Mutation Research 149(1): 141-146
Bryant, P.E.; Blöcher, D. 1982: The effects of 9-beta-D-arabinofuranosyladenine on the repair of DNA strand breaks in X-irradiated Ehrlich ascites tumour cells International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 42(4): 385-394
Iliakis, G. 1983: Effects of beta-arabinofuranosyladenine on potentially lethal damage induced in plateau phase mammalian cells exposed to U.V.-light International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 43(5): 529-540
Cass, C.E.; Selner, M.; Ferguson, P.J.; Phillips, J.R. 1982: Effects of 2'-deoxyadenosine, 9-beta-D-arabinofuranosyladenine, and related compounds on S-adenosyl-L-homocysteine hydrolase activity in synchronous and asynchronous cultured cells Cancer Research 42(12): 4991-4998
Jamieson, G.P.; Snook, M.B.; Bradley, T.R.; Bertoncello, I.; Wiley, J.S. 1989: Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells Cancer Research 49(2): 309-313
Earle, M.F.; Glazer, R.I. 1983: Activity and metabolism of 2-beta-D-ribofuranosylthiazole-4-carboxamide in human lymphoid tumor cells in culture Cancer Research 43(1): 133-137
Jacobsen, S.E.; Ruscetti, F.W.; Roberts, A.B.; Keller, J.R. 1993: TGF-beta is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-beta 1 and TGF-beta 3 Journal of Immunology 151(9): 4534-4544
LePage, G.A.; Khaliq, A.; Gottlieb, J.A. 1973: Studies of 9-beta-D-arabinofuranosyladenine in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(6): 756-759
Udaka, K.; Marusić-Galesić, S.; Walden, P. 1994: CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class i expression Journal of Immunology 153(6): 2843-2850
Kreis, W.; Gordon, C.S.; DeJager, R.; Krakoff, I.H. 1975: Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans Cancer Research 35(9): 2453-2460
Sass, J.O.; Masgrau, E.; Saurat, J.H.; Nau, H. 1995: Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(9): 887-891